Subcutaneous Biologics: The Unmet Requirement in the Pharmaceutical Space
Roots Analysis
MARCH 21, 2022
Subcutaneous drug delivery systems – the helping hand for patients. There has been a significant increase in the number of biologics, specifically the new generation molecules, such as monoclonal antibodies, in the late-stage clinical studies ( phase II / phase III ). Our Social Media Platform. Web: [link].
52 
Let's personalize your content